Results 151 to 160 of about 382,649 (338)

Donor Natural Killer Cell Ly49 Inhibitory Profile is Altered by Development in an MHC Mismatched Recipient Environment following In Utero Hematopoietic Stem Cell Transplantation

, 1999
Aimen F. Shaaban, Ross Milner, Heung Bae Kim, Christian Fichter, Alan W. Flake   +4 more
openalex   +1 more source

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome [PDF]

, 2001
W. Garrett Nichols, Lawrence Corey, Ted Gooley, Chris Davis, Michael Boeckh   +4 more
openalex   +1 more source

Expert Perspective: Hematologic Malignancies and Vasculitis

Arthritis &Rheumatology, EarlyView.
Michelle L. Robinette, Hetty E. Carraway
wiley   +1 more source

Beyond Simple Grinding: Methylammonium Chloride Promotes Sustainable, Cylinder‐Free Mechanochemical Synthesis of Deferiprone

ChemSusChem, EarlyView.
Deferiprone is synthesized under solvent‐free mechanochemical conditions using ball milling. Methylammonium chloride and KOH enable efficient substitution of the oxygen atom in the maltol scaffold with a methylamine moiety, avoiding the limitations of methylamine solutions.
Francesco Basoccu, Sara Piermarini, Tommaso Angelini, Massimiliano Mari, Edoardo Mariani, Alessandro Falchi, Andrea Porcheddu   +6 more
wiley   +1 more source

Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European Group for Blood and Marrow Transplantation (EBMT)

, 2000
Andrea Bacigalupo
openalex   +1 more source

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma [PDF]

, 2001
Luis F. Porrata, Morie A. Gertz, David J. Inwards, Mark R. Litzow, Martha Q. Lacy, Ayalew Tefferi, Dennis A. Gastineau, Angela Dispenzieri, Stephen M. Ansell, Ivana N. Micallef, Susan M. Geyer, Svetomir N. Markovic   +11 more
openalex   +1 more source

Unraveling genotype–phenotype associations and predictive modeling of outcome in acute myeloid leukemia

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Acute myeloid leukemia (AML) comprises 32% of adult leukemia cases, with a 5‐year survival rate of only 20–30%. Here, the immunophenotypic landscape of this heterogeneous malignancy is explored in a single‐center cohort using a novel quantitative computational pipeline.
Artuur Couckuyt, Sofie Van Gassen, Annelies Emmaneel, Vince Janda, Malicorne Buysse, Ine Moors, Jan Philippé, Mattias Hofmans, Tessa Kerre, Yvan Saeys, Sarah Bonte   +10 more
wiley   +1 more source

Autologous hematopoietic stem cell transplantation for mantle cell lymphoma

, 2000
Julie M. Vose, Philip J. Bierman, Dennis D. Weisenburger, James C. Lynch, Gregory Bociek, Wing C. Chan, Timothy C. Greiner, Jamés O. Armitage   +7 more
openalex   +1 more source

Treatment of Adenovirus Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [PDF]

, 2001
Pierre Bordigoni, Anne‐Sophie Carret, Véronique Venard, Francis Witz, Alain Le Faou   +4 more
openalex   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source